Jahangir E, Comandé D, Rubinstein A. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(12): 383-387 [PMID: 22216374 DOI: 10.4330/wjc.v3.i12.383]
Corresponding Author of This Article
Dr. Eiman Jahangir, MD, Institute for Clinical Effectiveness and Health Policy, Dr. Emilio Ravignani 2024, Buenos Aires, C1414CPV, Argentina. eiman.jahangir@vanderbilt.edu
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/